Royal Fund Management’s Global Medical REIT GMRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $768K | Buy |
110,805
+20,086
| +22% | +$139K | 0.08% | 189 |
|
|
2025
Q1 | $794K | Buy |
90,719
+7,888
| +10% | +$69K | 0.09% | 189 |
|
|
2024
Q4 | $640K | Sell |
82,831
-65,333
| -44% | -$504K | 0.06% | 181 |
|
|
2024
Q3 | $1.47M | Buy |
148,164
+70,066
| +90% | +$695K | 0.09% | 163 |
|
|
2024
Q2 | $709K | Sell |
78,098
-4,166
| -5% | -$37.8K | 0.06% | 190 |
|
|
2024
Q1 | $720K | Buy |
82,264
+5,247
| +7% | +$45.9K | 0.07% | 196 |
|
|
2023
Q4 | $855K | Buy |
77,017
+1,997
| +3% | +$22.2K | 0.09% | 178 |
|
|
2023
Q3 | $673K | Buy |
75,020
+564
| +0.8% | +$5.06K | 0.09% | 174 |
|
|
2023
Q2 | $680K | Sell |
74,456
-7,810
| -9% | -$71.3K | 0.08% | 174 |
|
|
2023
Q1 | $749K | Buy |
82,266
+11,066
| +16% | +$101K | 0.11% | 160 |
|
|
2022
Q4 | $675K | Buy |
71,200
+8,459
| +13% | +$80.2K | 0.11% | 148 |
|
|
2022
Q3 | $534K | Buy |
62,741
+16,246
| +35% | +$138K | 0.1% | 141 |
|
|
2022
Q2 | $522K | Buy |
46,495
+25,116
| +117% | +$282K | 0.09% | 144 |
|
|
2022
Q1 | $348K | Buy |
21,379
+3,714
| +21% | +$60.5K | 0.05% | 160 |
|
|
2021
Q4 | $313K | Buy |
17,665
+2,554
| +17% | +$45.3K | 0.04% | 160 |
|
|
2021
Q3 | $222K | Buy |
15,111
+2,283
| +18% | +$33.5K | 0.03% | 176 |
|
|
2021
Q2 | $189K | Buy |
+12,828
| New | +$189K | 0.03% | 186 |
|